Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Simona Simonetta"'
Autor:
Davide Dazzi, Lorenzo Pignataro, Guia Vannucchi, Danila Covelli, Nicola Currò, Simona Simonetta, Laura Fugazzola, Claudio Guastella, Giacinta Pirola, Elisa Lazzaroni, Irene Campi, Mario Salvi
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 31(2)
Background: The overall changes of ocular motility in Graves' orbitopathy (GO) are not easily quantifiable with the methods currently available, especially in clinical studies. The aim of the prese...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7384831ee2f17741bed1b6fb76d7053b
https://pubmed.ncbi.nlm.nih.gov/32940167
https://pubmed.ncbi.nlm.nih.gov/32940167
Autor:
Lorenzo Pignataro, Guia Vannucchi, Davide Dazzi, Simona Simonetta, Danila Covelli, Nicola Currò, Roberto Ratiglia, Mario Salvi, Irene Campi, Paolo Beck-Peccoz, Claudio Guastella, Giacinta Pirola
Publikováno v:
Thyroid. 24:897-905
While pulsed intravenous methylprednisolone (iv-MP) has been shown to be effective and well tolerated in moderate to severe Graves' orbitopathy (GO), limited data are available on dysthyroid optic neuropathy (DON). The objective of this retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::187cd6f0b00422ca4e50ad44c90aacd7
https://doi.org/10.1089/thy.2013.0445
https://doi.org/10.1089/thy.2013.0445
Autor:
Davide Dazzi, Marco Bonomi, Jack R. Wall, Paola Bonara, Irene Campi, Guia Vannucchi, Paolo Beck-Peccoz, Nicola Currò, Mario Salvi, Claudio Guastella, Danila Covelli, Luca Persani, Simona Simonetta
Publikováno v:
Clinical and Experimental Immunology. 161:436-443
Summary In active Graves' orbitopathy (GO), proinflammatory cytokines predominate. Circulating thyroid stimulating hormone (TSH)-receptor antibodies (TRAb) have been correlated with GO clinical activity and severity. In preliminary studies rituximab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1464996d8869794e5aeda3d7995c2de
https://doi.org/10.1111/j.1365-2249.2010.04191.x
https://doi.org/10.1111/j.1365-2249.2010.04191.x
Graves’ Orbitopathy Activation after Radioactive Iodine Therapy with and without Steroid Prophylaxis
Autor:
Davide Dazzi, Paolo Beck-Peccoz, Mario Salvi, Nicola Currò, Simona Simonetta, Danila Covelli, Roberto Ratiglia, Irene Campi, Guia Vannucchi
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 94:3381-3386
The reactivation of Graves' orbitopathy (GO) after radioiodine (RAI) for Graves' disease (GD) is a known effect, and its clinical relevance is controversial. Prevention of RAI-induced GO activation is possible in at-risk patients with oral glucocorti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c0d2fb80ec5952c807382c41404fee7
https://doi.org/10.1210/jc.2009-0506
https://doi.org/10.1210/jc.2009-0506
Autor:
Irene Campi, Sabrina Avignone, Danila Covelli, Guia Vannucchi, Claudio Guastella, Davide Dazzi, Lorenzo Pignataro, Simona Simonetta, Paolo Beck-Peccoz, Nicola Currò, Mario Salvi
Publikováno v:
The Journal of clinical endocrinology and metabolism. 100(2)
Preliminary studies have shown that rituximab (RTX) is effective in the treatment of active Graves' orbitopathy (GO).We conducted a double-blind, randomized trial (European Clinical Trials Database [EudraCT] 2007-003910-33) to compare RTX with iv met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d69a6d1cf8d1f28e756accf20b83f05
https://pubmed.ncbi.nlm.nih.gov/25494967
https://pubmed.ncbi.nlm.nih.gov/25494967